Drug Therapy For Preventing Ventricular Arrhythmia In Brugada syndrome: Do We Have The Answers Yet?
- PMID: 24130424
- PMCID: PMC3775319
- DOI: 10.1016/s0972-6292(16)30667-2
Drug Therapy For Preventing Ventricular Arrhythmia In Brugada syndrome: Do We Have The Answers Yet?
Keywords: Brugada syndrome; Drug Therapy; Ventricular Arrhythmia.
References
-
- Brugada P, et al. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report. J Am Coll Cardiol. 1992;20:1391. - PubMed
-
- Chen Q, et al. Genetic basis and molecular mechanism for idiopathic ventricular fibrillation. Nature. 1998;392:293. - PubMed
-
- Lukas A. Electrophysiology of myocardial cells in the epicardial, midmyocardial and endocardial layers of the ventricle. J Cardiovasc Pharmacol Ther. 1997;2:61. - PubMed
-
- Antzelevitch C, et al. Transmural dispersion of repolarization and arrhythmogenicity: the Brugada syndrome versus the long QT syndrome. J Electrocardiol. 1999;32(Suppl):158. - PubMed
-
- Antzelevitch C, et al. The Brugada syndrome: ionic basis and arrhythmia mechanisms. J Cardiovasc Electrophysiol. 2001;12:268. - PubMed
LinkOut - more resources
Full Text Sources